Alexandros Fotopoulos

This profile gathers the share dealings of Alexandros Fotopoulos in Passage BIO, Inc. The record holds 5 filings, for trades running from 3 March 2020 to 16 June 2023.

On the open market, the record shows 1 purchase worth €89k and 2 sales worth €8,281. The net balance comes to €81k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 option exercises. 2023 to date brings no purchases and 1 sale.

On 20 June 2023 came the latest disclosure, an open-market sale for €3,452 in Passage BIO, Inc. The last insider purchase was made public on 3 March 2020, 2,442 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.